MR radiomics predicts pathological complete response of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a multicenter study
Abstract Background More than 40% of patients with resectable esophageal squamous cell cancer (ESCC) achieve pathological complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT), who have favorable prognosis and may benefit from an organ-preservation strategy. Our study aims to develop an...
Main Authors: | Yunsong Liu, Yi Wang, Xin Wang, Liyan Xue, Huan Zhang, Zeliang Ma, Heping Deng, Zhaoyang Yang, Xujie Sun, Yu Men, Feng Ye, Kuo Men, Jianjun Qin, Nan Bi, Qifeng Wang, Zhouguang Hui |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Cancer Imaging |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40644-024-00659-x |
Similar Items
-
Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
by: Yunsong Liu, et al.
Published: (2024-11-01) -
Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis
by: Yunsong Liu, et al.
Published: (2023-01-01) -
Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma
by: Xiaofeng Duan, et al.
Published: (2025-01-01) -
Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
by: Fei Chen, et al.
Published: (2022-08-01) -
Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
by: Wing-Keen Yap, et al.
Published: (2022-11-01)